An interpretable machine learning framework for adverse drug reaction prediction from drug-target interactions
PLOS One · 30.01.2026 · 21 (1) · e0340900
DOI: 10.1371/journal.pone.0340900 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 30.01.2026. Verfasst von Joseph Roberts-Nuttall und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Mechanical Engineering, University of Birmingham, Edgbaston, United Kingdom. Hauptthemen laut MEDLINE: Drug-Related Side Effects and Adverse Reactions, Machine Learning. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Adverse drug reactions (ADRs) present challenges to patient safety and healthcare systems. Current pharmacovigilance methods, such as the Yellow Card Scheme (YCS), provide valuable post-marketing data, but the mechanistic causes of these ADRs are not fully understood. Leveraging drug-target interaction data with interpretable machine learning offers a promising approach to anticipate ADRs and understand their underlying mechanisms.
Objective
This study proposes an interpretable machine learning (ML) framework to predict significant ADRs using drug-target interaction data. The framework aims to identify key pharmacological relationships, helping to inform drug safety.
Methods
Drug-target interaction data from STITCH was combined with ADR reports from the YCS. Disproportionality analysis identified significant ADR signals which were used to train Random Forest classifiers across System Organ Class (SOC) categories. Class imbalance was addressed with SMOTE and Tomek, and Bayesian optimisation refined hyperparameters. Feature importance scores provided interpretability, and the top features were validated using known target-disease associations from DisGeNET.
Results
Prediction performance varied across SOC categories, with ROC AUC scores up to 0.94. Feature importance analysis identified pharmacologically relevant targets, validated using DisGeNET and comparisons with SIDER highlighted the added value of real-world data.
Conclusions
The interpretable ML framework links drug-target interactions to ADRs, offering a promising approach for predictive pharmacovigilance (PPV) and supporting safer drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- School of Mechanical Engineering, University of Birmingham, Edgbaston, United Kingdom.
- School of Pharmacy, University of Birmingham, Edgbaston, United Kingdom.
ORCID-Profile: Alan M Jones, Duc Pham
Zitieren
APA
Roberts-Nuttall, J., Jones, A. M., Castellani, M., & Pham, D. (2026). An interpretable machine learning framework for adverse drug reaction prediction from drug-target interactions. PLOS One, 21(1), e0340900. https://doi.org/10.1371/journal.pone.0340900
Vancouver
Roberts-Nuttall J, Jones AM, Castellani M, Pham D. An interpretable machine learning framework for adverse drug reaction prediction from drug-target interactions. PLOS One. 2026;21(1):e0340900. doi:10.1371/journal.pone.0340900
BibTeX
@article{RobertsNuttall2026,
author = {Roberts-Nuttall, Joseph and Jones, Alan M and Castellani, Marco and Pham, Duc},
title = {An interpretable machine learning framework for adverse drug reaction prediction from drug-target interactions},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {1},
pages = {e0340900},
doi = {10.1371/journal.pone.0340900}
}
EUVIMED